BRCA1 and cancer: We observed increased positive p53 immunohistochemical staining, which correlated with negative p21 immunostaining, in cancers with epigenetic BRCA1 loss, compared to cancers with BRCA1 mutations and high grade serous/undifferentiated cancers without BRCA1 loss.